Wed, Oct 22, 2014, 3:41 AM EDT - U.S. Markets open in 5 hrs 49 mins


% | $
Quotes you view appear here for quick access.

Verastem, Inc. (VSTM) Message Board

  • daggidoodle daggidoodle Jun 20, 2013 9:55 AM Flag

    Here's why I'm invested in Verastem

    Verastem (NASDAQ: VSTM) is made up of a team of who’s who scientists, board members, and executives from prestigious universities and Big Pharma companies around. The company is developing a therapeutic approach to use next generation chemotherapeutics to kill cancer stem cells. If the company is successful, a new approach to chemotherapy will be created, one that also attacks cancer recurrence; a large unmet medical need in cancer.

    An investment in Verastem might take a while to appreciate. The company’s most advanced study is VS-6063, which is being used to treat advanced solid tumors. Currently, it is being tested on both mesothelioma and ovarian cancer. According to the company, a regulatory filing could occur as early as early 2015 for this product.

    VS-6063 is just the beginning of the company’s pipeline. It then has VS-4718 to target cancer stem cells and a small molecule inhibitor VS-5584. With the chemotherapy market being $15 billion annually, and there being no form to prevent disease recurrence, it seems likely that Verastem's next generation chemotherapy could be very successful in this large market; although no peak sales have been established.

    Sentiment: Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
8.98-0.22(-2.39%)Oct 21 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.